Showing results (291-300 of 318) with videos related to
Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Heterocyclic ketones as inhibitors of histone deacetylaseAnil Vasudevan, Zhiqin Ji, Robin R Frey, et al.Thoracic Cancer|September 29, 2018
Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study)Yan Xu, Li Zhang, Jian Fang, et al.Cell Reports|December 14, 2022
Consumption of fish oil high-fat diet induces murine hair loss via epidermal fatty acid binding protein in skin macrophagesJiaqing Hao, Rong Jin, Jun Zeng, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.Future Oncology (London, England)|October 3, 2024
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050Xingxiang Pu, Juan Li, Bo Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplificationJun Guo, Lu Si, Yan Kong, et al.Lung Cancer (Amsterdam, Netherlands)|December 9, 2025
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA studyLin Wu, Junling Li, Chong-Rui Xu, et al.Translational Lung Cancer Research|January 13, 2023
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohortZihua Zou, Yangchun Gu, Li Liang, et al.BMC Cancer|April 8, 2020
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trialNan Bi, Lipin Liu, Jun Liang, et al.Cancer Medicine|September 24, 2017
Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014Yuanqiu Li, Jufang Shi, Shicheng Yu, et al.Pageof 32